Series D - Formation Bio

Series D - Formation Bio

Investment Firm

Overview

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

Announced Date

Jun 26, 2024

Funding Type

Series D

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Andreessen Horowitz

Andreessen Horowitz

Andreessen Horowitz is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorLachy Groom
Participant InvestorSV Angel
Participant InvestorAndreessen Horowitz
Participant InvestorEmerson Collective
Participant InvestorSequoia Capital

Round Details and Background

Formation Bio raised $372000000 on 2024-06-26 in Series D

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 15, 2018
Venture Round - Formation Bio
6-undefined
Sep 28, 2017
Seed Round - Formation Bio
2-undefined
Sep 30, 2021
Series C - Formation Bio
13-156.0M
Jun 26, 2024
Series D - Formation Bio
8-372.0M

Recent Activity

There is no recent news or activity for this profile.